SLC11A2 and ovarian carcinoma: Although the HR is not high as it looks, considering that most of the ovarian cancer nests are diffusely expressed in the immunohistochemical results and normal ovaries are completely negative, indicated that SLC11A2 is highly expressed in the vast majority of ovarian cancers.